“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Belgium opens beer temple in former stock market building
For U.S. investors sour on Apple, buying Samsung is tricky [2013]
Nearly Every Major Federal Agency Has Reduced Projected Furloughs
Marijuana Compound Fights Cancer; Human Trials Next
Former Troy DARE officer sentenced
Judge throws out Abu Ghraib detainees’ torture case citing jurisdiction
German pilot in WWII and American B-17 pilot he spared reunite 40 years later
Blackstone Selling 1,300 Atlanta Houses in Strategy Shift
Google to challenge telecoms with fleet of solar-powered balloons
Pot Is Legal, but Some Towns Won't Partake
Syria rebel chief rejects U.S.-Russia chemical weapons deal
Dental Abuse Seen Driven by Private Equity Investments [2012]
How Fed stimulus earns a profit for Treasury
A war the Pentagon doesn’t want
Wikipedia founder Jimmy Wales blasts UK Internet snooping